TULVEGIO
Live / Applied — Second extension granted (statement of use) (as of 03 Feb 2026)
What this means for you
Not registered yet, but its 26 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98468938
- Mark type
- Design + words
- Filed
- 26 Mar 2024
- Published for opposition
- 17 Sept 2024
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, experimental and novel cancer therapeutics
Owner
- Elevar Therapeutics, Inc., Fort Lee, NJ, US
- Elevar Therapeutics, Inc., Salt Lake City, UT, US
Prosecution history
- 04 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Feb 2026 — SOU EXTENSION 2 GRANTED
- 03 Feb 2026 — SOU EXTENSION 2 FILED
- 03 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 27 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Aug 2025 — SOU EXTENSION 1 GRANTED
- 26 Aug 2025 — SOU EXTENSION 1 FILED
- 26 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Jan 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 11 Oct 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 17 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Sept 2024 — PUBLISHED FOR OPPOSITION
- 28 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER